APA

Goudemand J., Peynet J., Chambost H., Négrier C., Briquel M. E., Claeyssens S., Derlon-Borel A., Guérois C., Caron C., Scherrmann J. M., Debray M. & Bridey F. (19990415). A cross-over pharmacokinetic study of a double viral inactivated factor IX concentrate (15 nm filtration and SD) compared to a SD factor IX concentrate. : Thrombosis and haemostasis.

Chicago

Goudemand J, Peynet J, Chambost H, Négrier C, Briquel M E, Claeyssens S, Derlon-Borel A, Guérois C, Caron C, Scherrmann J M, Debray M and Bridey F. 19990415. A cross-over pharmacokinetic study of a double viral inactivated factor IX concentrate (15 nm filtration and SD) compared to a SD factor IX concentrate. : Thrombosis and haemostasis.

Harvard

Goudemand J., Peynet J., Chambost H., Négrier C., Briquel M. E., Claeyssens S., Derlon-Borel A., Guérois C., Caron C., Scherrmann J. M., Debray M. and Bridey F. (19990415). A cross-over pharmacokinetic study of a double viral inactivated factor IX concentrate (15 nm filtration and SD) compared to a SD factor IX concentrate. : Thrombosis and haemostasis.

MLA

Goudemand J, Peynet J, Chambost H, Négrier C, Briquel M E, Claeyssens S, Derlon-Borel A, Guérois C, Caron C, Scherrmann J M, Debray M and Bridey F. A cross-over pharmacokinetic study of a double viral inactivated factor IX concentrate (15 nm filtration and SD) compared to a SD factor IX concentrate. : Thrombosis and haemostasis. 19990415.